1. China Stocks

  2. •

    Health services

  3. •

    Hospital/Nursing management
Hospital Corporation of China Ltd

Hospital Corporation of China Ltd

HHKEX:3869
3.40
HKD
0.00
(0.00%)
843.37MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
1.07
0.98
1.17
2.8
2.97
2.89
3.76
8.27
10.39
10.52
10.78
- -
Basic EPS, GAAP
- -
0.38
0.18
-0.11
-0.37
1.09
-2.93
-2.03
-3.48
0.96
-0.19
1
- -
Free Cash Flow per Basic Share
- -
0.05
1.15
0.36
0.66
0.37
0.53
0.85
0.92
0.46
1.44
0.99
- -
Dividend per Share
- -
- -
0.48
0.14
0.19
0.24
0.22
0.22
- -
- -
- -
- -
- -
Book Value per Share
7.8
8.18
8.4
10.96
9.58
10.73
7.82
5.77
1.85
2.76
2.47
3.68
3.68
Tangible Book Value per Share
-0.37
0.04
0.28
3.29
-11.67
-10.57
-8.44
-6.34
-6.82
-5.64
-6.13
-4.95
-4.95
Basic Weighted Avg Shares
138
133
133
127
137
138
138
138
138
137
137
136
136
Sales/Revenue/Turnover
- -
143
131
149
384
411
399
520
1,143
1,428
1,442
1,471
- -
Operating Margin (%)
- -
62.98
44.43
24.49
24.49
27.45
36.88
23.74
5.36
8.7
12.45
10.84
- -
Depreciation Expense
- -
7
7
6
30
44
43
41
63
69
63
62
- -
Net Income, GAAP
- -
51
24
-14
-50
151
-404
-281
-481
131
-26
136
- -
Effective Tax Rate (%)
- -
25.29
32.11
119.16
230.97
13.36
- -
- -
- -
22.14
64.33
25.49
- -
Profit Margin (%)
- -
35.74
18.39
-9.22
-13.16
36.73
-101.28
-53.95
-42.08
9.2
-1.81
9.27
- -
Working Capital
-19
56
112
254
144
785
785
650
-943
-712
-712
420
420
LT Debt
- -
- -
- -
215
1,248
1,794
1,593
1,000
6
936
7
999
999
Total Equity
1,061
1,129
1,161
1,562
1,668
1,818
1,367
1,136
443
591
576
721
721
Return on Invested Capital (%)
- -
6.02
3.48
-0.49
-1.81
4.47
- -
- -
- -
4.77
2.96
5
- -
Return on Capital (%)
- -
3.16
0.58
-2.47
-4.06
4.27
- -
- -
- -
4.68
-1.81
11.86
- -
Return on Common Equity (%)
- -
4.78
2.18
-1.04
-3.56
10.75
-31.55
-29.89
-91.29
41.39
-7.28
32.47
- -

Capital Structure

CNY

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
1,153
105
80
LT Borrowings
- -
937
981
LT Finance Leases
7
18
17
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
136
136
136
Market Capitalization
871
537
758

Working Capital

CNY

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
1,099
1,020
1,099
Cash, Cash Equivalents & STI
813
723
804
Accounts Receivable, Net
131
144
140
Inventories
31
16
22
Total Current Liabilities
1,811
668
678
Payables & Accruals
- -
- -
- -
ST Debt
1,153
105
80
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
0.64%
-4.4%
25.21%
Free Cash Flow
260.49%
40.12%
-31.07%
Net Income, GAAP
-153.88%
-165.86%
-622.89%
Sales/Revenue/Turnover
34.52%
35.59%
1.99%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
1,428
2024
- -
- -
1,442
2025
- -
- -
1,471

Semi-annual Earnings Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.96
2024
- -
- -
-0.19
2025
- -
- -
1

Semi-annual Dividends Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Xiaofeng Lang
Full Time Employees
1,809
Sector
Health services
Industry
Hospital/Nursing management
Address
Air China Century Plaza Beijing China
IPO Date
Mar 16, 2017
Website
hcclhealthcare.com
Similar Companies
Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP)
Max Healthcare Institute Ltd (NSE:MAXHEALTH)
Fortis Healthcare Ltd. (NSE:FORTIS)
Bangkok Dusit Medical Services Public Co. Ltd. (SET:BDMS)
Yatharth Hospital and Trauma Care Services Limited (NSE:YATHARTH)
HCA Healthcare, Inc. (NYSE:HCA)
Business
Hospital Corporation of China Limited (3869.HK) is an investment holding company principally engaged in the ownership, operation, and management of hospitals in the People's Republic of China. The company operates through three main segments: general hospital services, which provide outpatient and inpatient medical care including specialized treatments at facilities such as Yangsi Hospital, Cixi Hospital, and Jinhua Guangfu Oncological Hospital; hospital management services, encompassing comprehensive operation management, supply chain services for medical devices, Western and Chinese medicines, and other ancillary support to affiliated hospitals; and sale of pharmaceutical products, involving wholesale of pharmaceuticals and medical consumables through its retail pharmacy operations. Incorporated in 2014 and headquartered at Room 1602, Tower B, Jin Qiu International Building, No. 6 Zhichun Road, Haidian District, Beijing, the company primarily serves the domestic Chinese market, targeting patients seeking general and specialized healthcare in regions including Shanghai, Zhejiang, and Jinhua, with approximately 1,840 employees. It is a subsidiary of Vanguard Glory Limited and focuses on non-public general hospitals, emphasizing standardization, specialization, and branding to compete with public institutions. In recent developments, the group has optimized its supply chain management system to enhance procurement efficiency for medical materials across its hospitals, fully integrating a proprietary platform for devices, medicines, and herbal pieces as of 2024; it entered into guarantee and pledge agreements in September 2024 with Nanyang Commercial Bank and China Construction Bank to support financing for Jinhua Guangfu Hospital up to RMB66.66 million, reflecting ongoing operational financing activities; and continues to strengthen brand awareness amid China's expanding opening-up policies for foreign investment in healthcare, including wholly-owned hospitals in pilot cities.